Search
for
Sort by
Research 811–840 of 1000+
- Worldwide cohort study of 46, XY differences/disorders of sex development genetic diagnoses: geographic and ethnic differences in variants
- Hair loss
- Transgender and Migraine
- Androgens in SARS-CoV-2 Coronavirus Infections
- Understanding sex and gender disparities in COVID-19 mortality: a narrative review beyond biology
- Evaluation of Copper and Zinc Disturbances in the Patients of Alopecia
- The utilisation of cardiac risk ratio and non-HDL cholesterol markers to assess cardiovascular risk in type 2 diabetes males with lowered serum DHT
- PD23-06 CHANGE IN SEXUAL FUNCTION IN MEN WITH LUTS/BPH ASSOCIATED WITH LONG-TERM TREATMENT WITH DOXAZOSIN, FINASTERIDE, AND COMBINED THERAPY
- Assessment of Female Sexual Dysfunction in Patients with Premenopausal Female Pattern Hair Loss
- The Polycystic Ovary Syndrome Evolutionary Paradox: a Genome-Wide Association Studies–Based, in silico, Evolutionary Explanation
- Alopecia and hirsutism*
- Male pseudohermaphroditism due to 17β-hydroxysteroid dehydrogenase deficiency: Studies on the natural history of the defect and effect of androgens on gender role
- Revisiting dandruff
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Does prostaglandin D<sub>2</sub> hold the cure to male pattern baldness?
- Serum elevation of dehydroepiandrosterone sulfate associated with male pattern baldness in young men
- Hunting the genes in male‐pattern alopecia: how important are they, how close are we and what will they tell us?
- Acanthosis nigricans, insulin resistance and cutaneous virilism
- What can the hair tell us about COVID‐19?
- Gender Differences in Cardiac Hypertrophy
- Sex steroid hormones are associated with mortality in COVID-19 patients
- Changes of androgens levels in menopausal women
- Testosterone-stimulated weanlings as an alternative to castrated male rats in the Hershberger anti-androgen assay
- Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss.
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Alopecia and Hirsuties
- Female Androgenic Alopecia
- Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens
- Association of male pattern baldness with angiographic coronary artery disease severity and collateral development
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women